A role for quercetin in coronavirus disease 2019 (COVID‐19)Giuseppe Derosa, Francesco Di Pierro, Pamela Maffioli et al.|Phytotherapy Research|2020Cited by 299
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label StudyFrancesco Di Pierro, Sagheer Ahmed, Stefano Togni et al.|International Journal of General Medicine|2021Cited by 183
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical TrialFrancesco Di Pierro, Saeed Khan, Somia Iqtadar et al.|International Journal of General Medicine|2021Cited by 177
Effects of Telmisartan Compared with Eprosartan on Blood Pressure Control, Glucose Metabolism and Lipid Profile in Hypertensive, Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled 12-Month StudyGiuseppe Derosa, Roberto Fogari|Hypertension Research|2004Cited by 168
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trialFrancesco Di Pierro, Nicola Zerbinati, Martino Recchia et al.|Frontiers in Pharmacology|2023Cited by 54